METTL3 and non-small cell lung carcinoma: In several NSCLC models, METTL3 cooperates with translation initiation machinery (e.g., eIF3h) to increase the translational efficiency of oncogenic transcripts, thereby sustaining proliferation, invasion, and therapy tolerance.